The impact of the Covid-19 pandemic on patients with schizophrenia.

Vita, Antonio; Barlati, Stefano

Vita, Antonio; Barlati, Stefano.

Vita A; Department of Clinical and Experimental Sciences, University of Brescia; Brescia, Italy; Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy. Electronic address: antonio.vita@unibs.it.
Barlati S; Department of Clinical and Experimental Sciences, University of Brescia; Brescia, Italy; Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.

Eur Neuropsychopharmacol ; 54: 62-64, 2022 01.

Article in English | MEDLINE | ID: covidwho-1356231

Subject(s)

COVID-19/psychology; Schizophrenia/epidemiology; Schizophrenic Psychology; COVID-19/epidemiology; COVID-19/prevention & control; Continuity of Patient Care; Humans; Pandemics; SARS-CoV-2; Sickness Impact Profile; Telemedicine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / Schizophrenic Psychology / COVID-19 Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal: Eur Neuropsychopharmacol Journal subject: Psychopharmacology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google